About Regulatory Science at USC:
About Careers in Regulatory Science:
“Options in regulatory affairs – specialties and skill sets” by RegSci faculty member
More Career Info:
Published in Food, Medicine, & Health by RegSci faculty member Dr. Roger Clemens:
White papers, articles, & publications
Postmarket Surveillance in a Digital Health Solution World, by Darin Oppenheimer DRSc (’17), Guo, Hale, Cusatis, Ramachandran, & Visc0
Medical Device and Risk Management, by Darin Oppenheimer DRSc (’17) and Suraj Ramachandran (RAPS, 14 February 2018)
Connected Device System Validation & Quality – Best Practices; by Carolyn Wright, USC Reg Sci DRSc student (JVT Journal, August 2017)
Organizational Culture and Memory in Managing Risk in the Medical Device Industry; by Darin Oppenheimer, DRSc & Suraj Ramachandran (Regulatory Affairs Professional Society, August 2017)
Standard Comparison: Assessing risk management processes for regulated health industries; by Carolyn Wright, USC RegSci DRSc student (Quality Progress, June 2017)
What’s Behind Medtech’s Recall Epidemic? Part 3: Production Controls; Joshua R. Dix, Suraj Ramachandran, and Darin S. Oppenheimer (July 2016)
What’s Behind Medtech’s Recall Epidemic? Part 2: Software Controls. Joshua R. Dix, Suraj Ramachandran, and Darin S. Oppenheimer (July 2016)
What’s Behind Medtech’s Recall Epidemic? Part 1: Device Design. Joshua R. Dix, Suraj Ramachandran, and Darin S. Oppenheimer (June 2016)
Role of Purinergic P2X4 Receptors in Regulating Striatal Dopamine Homeostasis and Dependent Behaviors. Journal of Neurochemistry; Khoja S, Shah V, Garcia D, Asatryan L, Jakowec MW, Davies DL. Accepted for publication; in press.
Navigating the Paradigm Shift in Biomedical Research and Development: Orphan Drug Regulation and Product Development Strategy; Eunjoo Pacifici, PharmD, PhD
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder; Daryl Davies, Ph.D. et all (April 2016)
Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals; Daryl Davies, Ph.D. et all (March 2016)
ICH Revisions for Benefit-risk Assessment by Nancy Smerkanich, DRSc (January 2016)
Incentivizing Quality in the Manufacture of Pharmaceuticals: Industry Views on Quality Metrics and Ratings; Cesar Medina, DRSc and Frances Richmond, PhD (May 2015).
Cultivating Talent for Korea’s Biopharmaceutical Industry; Eunjoo Pacifici, PharmD, PhD:
Options in Regulatory Affairs- Specialties and Skill Sets; Nancy Pire-Smerkanich and David Locke (March 2015)
Escalation of Oncologic Services at the End of Life Among Patients with Gynecologic Cancer at an Urban Public Hospital; Terry Church, et al (February 2015).
Our students are leaders in their respective industries as well as in their academic contributions to the field of regulatory science.